See more : Scienture Holdings, Inc. (SCNX) Income Statement Analysis – Financial Results
Complete financial analysis of MJ Holdings, Inc. (MJNE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MJ Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Kinarus Therapeutics Holding AG (PRFN.SW) Income Statement Analysis – Financial Results
- CareDx, Inc (CDNA) Income Statement Analysis – Financial Results
- Jiangxi Yuean Advanced Materials Co.,Ltd. (688786.SS) Income Statement Analysis – Financial Results
- Pretium Resources Inc. (PVG.TO) Income Statement Analysis – Financial Results
- Cloud Nine Web3 Technologies Inc. (CNI.CN) Income Statement Analysis – Financial Results
MJ Holdings, Inc. (MJNE)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.mjholdingsinc.com
About MJ Holdings, Inc.
MJ Holdings, Inc., a cannabis holding company, engages in cultivation management, asset, and infrastructure development business in Nevada. It is also involved in production of cannabis related products; and provision of management services, dispensaries, and consulting services. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 362.31K | 241.87K | 822.85K | 897.70K | 8.15K | 0.00 | 9.04K | 625.86K | 108.87K | 0.00 | 0.00 | 0.00 | 2.72K |
| Cost of Revenue | 0.00 | 341.63K | 1.21M | 1.19M | 10.00K | 0.00 | 0.00 | 123.59K | 72.86K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 362.31K | -99.76K | -384.12K | -290.03K | -1.85K | 0.00 | 9.04K | 502.28K | 36.01K | 0.00 | 0.00 | 0.00 | 2.72K |
| Gross Profit Ratio | 100.00% | -41.24% | -46.68% | -32.31% | -22.70% | 0.00% | 100.00% | 80.25% | 33.08% | 0.00% | 0.00% | 0.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.53M | 8.18M | 2.98M | 6.77M | 4.19M | 270.27K | 92.60K | 257.32K | 1.06M | 24.96K | 13.61K | 0.00 | 25.97K |
| Selling & Marketing | 30.22K | 69.76K | 7.90K | 15.97K | 486.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.56M | 8.25M | 2.99M | 6.79M | 4.68M | 270.27K | 92.60K | 257.32K | 1.06M | 24.96K | 13.61K | 20.06K | 25.97K |
| Other Expenses | 230.62K | 293.94K | 453.89K | 371.51K | 123.26K | 0.00 | 95.00 | 226.12K | 111.03K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.79M | 8.55M | 3.44M | 7.16M | 4.80M | 270.27K | 93.27K | 483.43K | 1.17M | 24.96K | 13.61K | 20.06K | 25.97K |
| Cost & Expenses | 3.79M | 8.89M | 4.65M | 8.35M | 4.81M | 270.27K | 93.27K | 483.43K | 1.17M | 24.96K | 13.61K | 20.06K | 25.97K |
| Interest Income | 120.19K | 20.27K | 18.35K | 10.54K | 598.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 78.22K | 110.68K | 167.19K | 127.66K | 15.15K | 64.52K | 0.00 | 254.21K | 104.35K | 4.20K | 4.25K | 2.94K | 1.62K |
| Depreciation & Amortization | 230.62K | 397.70K | 668.98K | 521.52K | 123.26K | 270.27K | 667.00 | 102.53K | 38.17K | 1.43K | 2.08K | 1.66K | 2.19K |
| EBITDA | -5.07M | 4.32M | -3.14M | -7.62M | -4.87M | 0.00 | -83.46K | -154.85K | -1.13M | -27.32K | 2.08K | 1.66K | -21.06K |
| EBITDA Ratio | -1,399.73% | -2,394.99% | -381.35% | -723.96% | -57,448.11% | 0.00% | -924.45% | 39.14% | -939.24% | 0.00% | 0.00% | 0.00% | -773.51% |
| Operating Income | -3.42M | -8.65M | -3.83M | -7.45M | -4.81M | -270.27K | -84.23K | 142.43K | -1.06M | -24.96K | -13.61K | -20.06K | -23.25K |
| Operating Income Ratio | -945.12% | -3,575.10% | -464.88% | -830.14% | -58,967.79% | 0.00% | -931.83% | 22.76% | -974.30% | 0.00% | 0.00% | 0.00% | -854.08% |
| Total Other Income/Expenses | -1.96M | 12.45M | -147.88K | -819.75K | -202.05K | -64.52K | 95.00 | 53.00 | 4.52K | -7.99K | -4.25K | -2.94K | -1.42K |
| Income Before Tax | -5.38M | 3.81M | -3.97M | -8.27M | -5.01M | -334.79K | -84.13K | -111.78K | -1.17M | -32.95K | -17.86K | -23.00K | 0.00 |
| Income Before Tax Ratio | -1,484.97% | 1,574.12% | -482.85% | -921.45% | -61,446.97% | 0.00% | -930.78% | -17.86% | -1,070.15% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 277.00K | 158.68K | 444.77K | -186.90K | -270.27K | -178.68K | 0.00 | 0.00 | 4.20K | 0.00 | 0.00 | 1.62K |
| Net Income | -5.38M | 3.53M | -4.13M | -8.72M | -5.01M | -334.79K | 94.55K | -111.78K | -1.17M | -32.95K | -17.86K | -23.00K | -24.87K |
| Net Income Ratio | -1,484.97% | 1,459.60% | -502.14% | -971.00% | -61,446.97% | 0.00% | 1,046.01% | -17.86% | -1,070.15% | 0.00% | 0.00% | 0.00% | -913.67% |
| EPS | -0.07 | 0.05 | -0.06 | -0.15 | -0.08 | -0.01 | 0.01 | -0.01 | -0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.07 | 0.05 | -0.06 | -0.15 | -0.08 | -0.01 | 0.01 | -0.01 | -0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 74.89M | 70.46M | 65.88M | 57.64M | 64.68M | 53.15M | 14.03M | 13.96M | 13.46M | 12.22M | 12.20M | 12.19M | 12.19M |
| Weighted Avg Shares Out (Dil) | 74.89M | 70.67M | 65.88M | 57.64M | 64.68M | 53.15M | 14.03M | 13.96M | 13.46M | 12.22M | 12.20M | 12.19M | 12.19M |
MJ Holdings Inc., Announces Upgraded Listing From OTC Pink Sheets to OTCQB
LAS VEGAS, Nevada, Sept. 14, 2021 (GLOBE NEWSWIRE) -- MJ Holdings, Inc. (“MJ Holdings” or the “Company”)(OTCQB: MJNE) is pleased to announce that the Company has received approval from the OTC Markets Group to begin trading on the OTCQB Market...
MJ Holdings Receives Approval to Transfer Cultivation Licenses to The Farm - a 260 Acre Farm in Amargosa Valley
LAS VEGAS, Sept. 08, 2021 (GLOBE NEWSWIRE) -- MJ Holdings, Inc. (“MJ Holdings” or the “Company”)(OTC Pink: MJNE) is proud to announce the Company has received a unanimous vote approving a Special Use Permit from the Nye County Board of...
MJ Holdings Highlights its Progress in the First Quarter
Reconstituting the C-Suite in 2020 is beginning to show positive results in 2021
MJ Holdings Clarifies The Timing Of The Sale Of Its Healthier Choices Management Corp. Common Stock
MJ Holdings clarifies its previous press release dated May 25, 2021 to explain the sale of its HCMC common stock was completed in February 2021.
Source: https://incomestatements.info
Category: Stock Reports